Default: Molecular Cancer

ISSN:

Journal Home

Journal Guideline

Molecular Cancer Q1 Unclaimed

BioMed Central Ltd. United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Molecular Cancer is a journal indexed in SJR in Molecular Medicine and Oncology with an H index of 126. It is an CC BY + CC0 Journal with a Single blind Peer Review review system, and It has a price of 3890 €. The scope of the journal is focused on oncology, tumour biology, cancer antigens. It has an SJR impact factor of 7,274 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 7,274.

Molecular Cancer focuses its scope in these topics and keywords: expression, colon, cells, prostate, cell, cancer, association, suppresses, methylation, proliferation, ...

Type: Journal

Type of Copyright: CC BY + CC0

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Price

3890 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Molecular Cancer

7,274

SJR Impact factor

126

H Index

166

Total Docs (Last Year)

511

Total Docs (3 years)

13682

Total Refs

12320

Total Cites (3 years)

478

Citable Docs (3 years)

25,55

Cites/Doc (2 years)

82,42

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


expression, colon, cells, prostate, cell, cancer, association, suppresses, methylation, proliferation, tumorigenesis, human, carcinoma, promoter, promotes, survival, trail, receptor, lung, cancerassociated, cancertransducin, oncology, tumour biology, cancer antigens

FAQS